The results provide insight into a new role of SOCS3 in modulation of Ly6C(+) monocyte phenotypes and provide a novel therapeutic strategy for ALI by molecular intervention of macrophages subtypes. The gene discussed is SOCS3; the disease is acute respiratory distress syndrome.